RESEARCH TRIANGLE PARK, NC--(Marketwire - May 3, 2010) - The market for diabetes drugs will expand about 70% by 2015, according to forecasting research from consulting firm Cutting Edge Information.
An expanding global patient population for Type 2 diabetes will drive this growth in both industrialized and developing nations. At the same time, drug developers are working on breakthrough therapies that treat this form of diabetes in new ways, but without some of the side effects of current options.
To support companies operating in this market, Cutting Edge Information (http://www.cuttingedgeinfo.com/) has combined its two best-selling diabetes research reports.
"Companies large and small can use our real-company diabetes market forecasts and diabetes MSL program benchmarks to build competitive advantage and stretch their goals in the next five years," said Jason Richardson, president of Cutting Edge Information. "We want to help clients strengthen their diabetes portfolios and move as quickly as they can to build the strongest possible brands."
The first report in the package, "Diabetes Market Forecast to 2015," (http://www.cuttingedgeinfo.com/diabetes-forecast/) helps product teams assess the overall diabetes landscape. Data include:
- Historical sales data and forecasts through 2015 for every important diabetes drug, along with the stories behind sales numbers and projections
- Recent clinical results that will affect each drug's future
- Profiles of 8 major diabetes manufacturers and 2 up-and-comers, including strategies, strengths and weaknesses
- Insights from leading endocrinology thought leaders about current and future treatments
Once a company assesses where it stands in the growing diabetes market, "The Toolkit for Diabetes MSL Programs" (http://www.cuttingedgeinfo.com/msl-diabetes/) can be used to optimize MSL program goals. This report will help companies:
- Save time and money by identifying the right Key Opinion Leaders
- Stay competitive with MSL recruitment
- Improve MSL and KOL communication
- Determine competitive KOL FMV compensation
The two reports contain more than 250 metrics spanning 45 diabetes product franchises.
"Approximately 246 million people worldwide have diabetes; this number is expected to increase to 380 million by 2025, according to the International Diabetes Foundation," added Richardson. "Such staggering figures solidify diabetes' position as a primary therapeutic area for Life Sciences."
For more information about Cutting Edge Information's market forecasts, visit the company website: http://www.cuttingedgeinfo.com/reports/forecasting-market-research.php
Contact Information:
CONTACT:
Stephanie Swanson
(919) 433-0212